anurajms/meta_analysis huggingface dataset:
outcomes:
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
1. All Cause Mortality 2. Tuberculosis 3. Hepatotoxicity
outcomes:
Combined oral contraceptives: venous thrombosis
1. Acute Deep Venous Thrombosis 2. Venous Thrombosis 3. Death 4. Acute Pulmonary Embolism
outcomes:
Blood pressure lowering efficacy of nonselective beta‐blockers for primary hypertension
1. Withdrawn From Research Study 2. Blood Pressure Alteration 3. Finding Of Arterial Pulse Pressure 4. Alteration In Heart Rate 5. Adverse Event
outcomes:
First‐line beta‐blockers versus other antihypertensive medications for chronic type B aortic dissection
1. All Cause Mortality
outcomes:
Insulin for glycaemic control in acute ischaemic stroke
1. Death
outcomes:
Endovascular repair of abdominal aortic aneurysm
1. Death 2. Complication
outcomes:
Antibiotics and antiseptics for venous leg ulcers
1. Wound Healing
outcomes:
Intravascular brachytherapy for peripheral vascular disease
1. Repeat surgery 2. Vascular graft restenosis 3. Primary Patency
outcomes:
Treatment of hypertension in peripheral arterial disease
1. All Cause Mortality 2. Cardiovascular Event 3. Cardiovascular Mortality
outcomes:
Immunosuppressive T‐cell antibody induction for heart transplant recipients
1. Infection 2. Lymphoproliferative disorder 3. Transplanted Organ Rejection 4. Cytomegalovirus Infection 5. Death 6. Cancer
outcomes:
Blood pressure targets for hypertension in people with diabetes mellitus
1. All Cause Mortality 2. Serious Adverse Event 3. Cardiovascular observations 4. Death 5. Cardiovascular Mortality
outcomes:
Corticosteroids for viral myocarditis
1. Complication 2. Death 3. Combined endpoint
outcomes:
Beta blockers for peripheral arterial disease
1. Claudication
outcomes:
Nitrates for acute heart failure syndromes
1. Dyspnea 2. Patient Satisfaction Score 3. Fatigue 4. Clinical status
outcomes:
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
1. Venous Thrombosis
outcomes:
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post‐stroke spasticity
1. Functional ability
outcomes:
Occupational therapy for care home residents with stroke
1. Activities of Daily Living 2. Moody 3. Costs and Cost Analysis 4. Rivermead Mobility Index Score 5. Death 6. Adverse Event 7. Barthel Index
outcomes:
Early versus delayed mobilisation for aneurysmal subarachnoid haemorrhage
1. Recurrent Hemorrhage 2. Death
outcomes:
Continuous versus intermittent physiological monitoring for acute stroke
1. Disability 2. All Cause Mortality 3. Death
outcomes:
Flavonoids for treating venous leg ulcers
1. Venous leg ulcer
outcomes:
Cholesterol‐reducing agents for aneurysmal subarachnoid haemorrhage
1. Persistent Vegetative State 2. Disability - Severe 3. Death
outcomes:
Non‐pharmacological interventions for preventing secondary vascular events after stroke or transient ischemic attack
1. Stroke 2. Myocardial Infarction 3. Cardiovascular Mortality
outcomes:
Physical rehabilitation for older people in long‐term care
1. Activities of Daily Living
outcomes:
Hypothermia for neuroprotection in children after cardiopulmonary arrest
1. Neurological Finding 2. Survival
outcomes:
Wolbachia‐carrying Aedes mosquitoes for preventing dengue infection
1. Dengue infection 2. Dengue fever
outcomes:
Vaccines for preventing herpes zoster in older adults
1. Injection Site Reaction 2. Serious Adverse Event 3. Herpes Zoster 4. Death 5. Hospitalization 6. Withdrawal Due To Adverse Events 7. Hypersensitivity Disorder Mediated By Immune Complex 8. Adverse Event
outcomes:
Antiplatelet agents for the treatment of adults with COVID‐19
1. All Cause Mortality 2. Serious Adverse Event 3. Clinical status 4. Haemorrhage 5. Thrombotic event 6. Adverse Event
outcomes:
Balanced crystalloid solutions versus 0.9% saline for treating acute diarrhoea and severe dehydration in children
1. Death 2. Duration Of Hospital Stay
outcomes:
Therapeutics for treating mpox in humans
1. Serious Adverse Event 2. Pain 3. Skin Lesion 4. Death 5. Hospitalization 6. Viral load
outcomes:
Hyperimmune immunoglobulin for people with COVID‐19
1. All Cause Mortality 2. Serious Adverse Event 3. Quality of Life 4. Clinical status 5. Adverse Event
outcomes:
Remdesivir for the treatment of COVID‐19
1. Invasive Mechanical Ventilation 2. All Cause Mortality 3. Serious Adverse Event 4. Quality of Life 5. Clinical status 6. Adverse Event
outcomes:
Systemic corticosteroids for the treatment of COVID‐19: Equity‐related analyses and update on evidence
1. All Cause Mortality 2. Serious Adverse Event 3. Hospital Acquired Infection 4. Quality of Life 5. Adverse Event 6. Symptoms worsening 7. Clinical Improvement
outcomes:
Ivermectin for preventing and treating COVID‐19
1. COVID-19 2. Mental Health Crisis Resolution 3. All Cause Mortality 4. Viral clearance 5. Hospital admission 6. Quality of Life 7. Clinical status 8. Duration Of Hospital Stay 9. SARS-CoV-2 Virus 10. Adverse Event
outcomes:
SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
1. COVID-19 2. WHO Clinical Progression Scale 3. SARS-CoV-2 Virus 4. Reverse transcription polymerase chain reaction
outcomes:
Janus kinase inhibitors for the treatment of COVID‐19
1. Severe COVID-19 2. Moderate COVID-19 3. Hospitalization
outcomes:
Inhaled corticosteroids for the treatment of COVID‐19
1. Infection 2. All Cause Mortality 3. Serious Adverse Event 4. Quality of Life 5. Death 6. Clinical Resolution 7. Hospitalization 8. Adverse Event
outcomes:
Antibiotics for the treatment of COVID‐19
1. All Cause Mortality 2. Serious Adverse Event 3. Cardiac Arrhythmia 4. Quality of Life 5. Clinical status 6. Adverse Event
outcomes:
Colchicine for the treatment of COVID‐19
1. All Cause Mortality 2. Serious Adverse Event 3. Quality of Life 4. Clinical Resolution 5. Clinical status 6. Adverse Event
outcomes:
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
1. All Cause Mortality 2. Serious Adverse Event 3. WHO Clinical Progression Scale 4. Quality of Life 5. Death 6. Adverse Event 7. Emergency Hospital Admission
outcomes:
Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV
1. All Cause Mortality 2. Tuberculosis 3. Mycobacterial culture 4. Death
outcomes:
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis
1. Urologicals 2. Quality of Life 3. Adverse Event
outcomes:
Effect of mass deworming with antihelminthics for soil‐transmitted helminths during pregnancy
1. Anemia
outcomes:
Topical microbicides for preventing sexually transmitted infections
1. Herpes Simplex 2. Chlamydial Infection 3. Infection By Trichomonas 4. Syphilis 5. Sexually Transmitted Infection 6. Gonorrhea 7. HIV infection
outcomes:
Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation
1. Death 2. Withdrawal Due To Adverse Events 3. Allergic Reaction To Antibiotics 4. Gastrointestinal Complication 5. Respiratory Tract Infection
outcomes:
Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID‐19 infection
1. COVID-19 2. Anosmia
outcomes:
Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them
1. COVID-19 2. Healthcare Professional 3. Anosmia 4. Referral To Hospital 5. Death 6. Mechanical ventilation 7. Renal Dialysis
outcomes:
Video calls for reducing social isolation and loneliness in older people: a rapid review
1. Loneliness 2. Quality of Life 3. Depression 4. Social Isolation 5. Patient-Reported Outcome
outcomes:
Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
1. All Cause Mortality 2. Relapse 3. Serious Adverse Event 4. Tuberculosis 5. Treatment Failure 6. Acquired drug resistance 7. Drug Resistance
outcomes:
Antibiotics for asymptomatic bacteriuria in pregnancy
1. Pyelonephritis 2. Low Birth Weight Infant 3. Preterm Infant
outcomes:
Intra‐pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema
1. Serious Adverse Event 2. Treatment Failure 3. Death 4. Referral To Thoracic Surgery Service
outcomes:
Rapid initiation of antiretroviral therapy for people living with HIV
1. All Cause Mortality 2. Increased Human Immunodeficiency Virus (hiv) Viral Load 3. Death
outcomes:
Community‐based antibiotic delivery for possible serious bacterial infections in neonates in low‐ and middle‐income countries
1. Treatment Failure 2. Death 3. Sepsis 4. Adverse Event
outcomes:
Primary antifungal prophylaxis for cryptococcal disease in HIV‐positive people
1. All Cause Mortality 2. Clinical resistance 3. Serious Adverse Event 4. Cryptococcosis 5. Death 6. Treatment discontinued 7. Antimicrobial resistance 8. Adverse Event
outcomes:
Early versus delayed antiretroviral treatment in HIV‐positive people with cryptococcal meningitis
1. All Cause Mortality 2. Relapse 3. Cryptococcal meningitis 4. Immune Reconstitution Inflammatory Syndrome Caused By Human Immunodeficiency Virus Infection 5. Increased Human Immunodeficiency Virus (hiv) Viral Load 6. Viral Load
outcomes:
Influenza vaccine for chronic obstructive pulmonary disease (COPD)
1. Disability 2. Death 3. Hospitalization 4. COPD Exacerbation
outcomes:
Interventions for necrotizing soft tissue infections in adults
1. Death 2. Adverse Event
outcomes:
Interventions to increase influenza vaccination rates of those 60 years and older in the community
1. Influenza Virus Vaccine
outcomes:
Osmotic therapies added to antibiotics for acute bacterial meningitis
1. Nausea And Vomiting 2. Hearing impairment 3. Neurological Impairment 4. Diarrhoea 5. Seizure 6. Gastrointestinal Bleeding
outcomes:
Antidepressants for depression in adults with HIV infection
1. Withdrawn From Research Study 2. Quality of Life 3. Depression 4. Cd4 Lymphocytes 5. Adverse Event 6. Clinical Improvement
outcomes:
Corticosteroids for pneumonia
1. All Cause Mortality 2. Treatment Failure
outcomes:
Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults
1. Serious Adverse Event 2. Microbial Culture Finding 3. Clinical Cure 4. Adverse Event 5. Clinical Improvement
outcomes:
Interventions to increase tuberculosis case detection at primary healthcare or community‐level services
1. Tuberculosis 2. Treatment Success 3. Treatment Failure 4. Death
outcomes:
Routine antibiotic prophylaxis after normal vaginal birth for reducing maternal infectious morbidity
1. Single organ failure 2. Urinary Tract Infection 3. Sepsis 4. Hospitalization 5. Hysterectomy 6. Intensive Care 7. Laparotomy 8. Endometritis 9. Therapy Failure Due To Antibiotic Resistance 10. Wound Infection
outcomes:
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
1. Adverse Drug Reaction 2. Treatment Failure 3. Death 4. Antibiotic Therapy
outcomes:
Short‐course versus long‐course intravenous therapy with the same antibiotic for severe community‐acquired pneumonia in children aged two months to 59 months
1. Relapse 2. Treatment Failure 3. Death 4. Complication 5. Hospitalization 6. Clinical Cure
outcomes:
Intravenous immunoglobulin for the treatment of childhood encephalitis
1. Disability 2. Hospitalization 3. Adverse Event
outcomes:
Probiotics for preventing urinary tract infection in people with neuropathic bladder
1. Urinary Tract Infection
outcomes:
Isoniazid for preventing tuberculosis in HIV‐infected children
1. Active Tuberculosis 2. Death
outcomes:
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children
1. Respiratory Disorders 2. Treatment Failure 3. Wheezing 4. Hospitalization
outcomes:
Zinc supplementation for the treatment of measles in children
1. All Cause Mortality 2. Time-to-Event 3. Fever
outcomes:
Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease
1. Acute Exacerbation Of Chronic Obstructive Airways Disease 2. Acute Exacerbation Of Chronic Bronchitis 3. Quality of Life 4. Haemophilus Influenzae 5. Death 6. Hospitalization 7. Adverse Event 8. Antibiotic Therapy
outcomes:
Antibiotics for acute bronchitis
1. Sputum 2. Acute Bronchitis 3. Cough
outcomes:
Pre‐admission antibiotics for suspected cases of meningococcal disease
1. Treatment Failure 2. Neurological Deficit 3. Death 4. Adverse Event 5. Meningococcal Meningitis
outcomes:
Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers
1. Surgical Site Infection 2. Death 3. Adverse Event 4. Infection Due To Staphylococcus Aureus
outcomes:
Surgical versus non‐surgical management for pleural empyema
1. Death 2. Complication 3. Hospitalization
outcomes:
Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock
1. Death 2. Antibiotic Therapy
outcomes:
Dressings for the prevention of surgical site infection
1. Surgical Site Infection 2. Scarring
outcomes:
Antiviral agents for infectious mononucleosis (glandular fever)
1. Lymphadenopathy 2. Duration of Symptom 3. Adverse Drug Reaction 4. Clinical Resolution 5. Complication 6. Infectious Mononucleosis 7. Absenteeism 8. Viral shedding 9. Adverse Event 10. Time-to-Event
outcomes:
One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates
1. Treatment Failure 2. Sepsis 3. Nephrotoxicity 4. Ototoxicity
outcomes:
School‐based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents
1. Early sexual debut 2. Syphilophobia 3. Pregnancy 4. Human immunodeficiency virus transmission 5. Sexually Transmitted Infection 6. Male Condom
outcomes:
Topical antibiotics for preventing surgical site infection in wounds healing by primary intention
1. Surgical Site Infection 2. Anaphylaxis 3. Allergic Contact Dermatitis 4. Antibiotic resistance test 5. Wound Healing 6. Adverse Event
outcomes:
Fluid therapy for acute bacterial meningitis
1. Neurological Morbidity 2. Death
outcomes:
Antibiotics for ventilator‐associated pneumonia
1. All Cause Mortality 2. Duration Of Hospital Stay 3. Clinical Cure 4. Intensive Care 5. Adverse Event
outcomes:
HIV prevention advice for people with serious mental illness
1. Sexually Provocative Behavior 2. Unprotected Sexual Intercourse 3. Risk Behavior Assessment 4. Quality of Life 5. Hospitalization 6. HIV infection 7. Shares Needles
outcomes:
Interventions for men and women with their first episode of genital herpes
1. Genital Herpes Simplex 2. Pain 3. Disease Recurrence 4. Adverse Event 5. Genital Lesion
outcomes:
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
1. Influenza 2. Complication 3. Absenteeism 4. Adverse Event
outcomes:
Behavioral interventions for improving contraceptive use among women living with HIV
1. Attitude Towards Care 2. Pregnancy 3. Contraception 4. Assessment Of Understanding Of Medication
outcomes:
Corticosteroids for treating nerve damage in leprosy
1. Assessment Using Assessment Scale 2. Medical Research Council Motor Power Scale 3. Tenderness 4. Loss Of Touch Sensation 5. Limitation Of Activities Due To Disability
outcomes:
Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis
1. Seizure 2. Seizure Free 3. Intensive Care
outcomes:
Fixed‐dose combinations of drugs versus single‐drug formulations for treating pulmonary tuberculosis
1. Relapse 2. Serious Adverse Event 3. Death 4. Treatment discontinued 5. Sputum Culture Conversion
outcomes:
Systemic antifungal therapy for tinea capitis in children
1. Clinical Cure
outcomes:
Corticosteroids for managing tuberculous meningitis
1. Death 2. Adverse Event
outcomes:
Early removal versus expectant management of central venous catheters in neonates with bloodstream infection
1. Visual Disability 2. Hearing impairment 3. Blindness 4. Developmental Delay 5. Death 6. Developmentally Disabled 7. Cerebral Palsy 8. Neurodevelopmental Delay 9. Hearing Disability
outcomes:
Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women
1. Urinary Frequency 2. Abdominal Pain 3. Adverse Event 4. Dysuria
outcomes:
Antihelminthics in helminth‐endemic areas: effects on HIV disease progression
1. Anemia 2. Death 3. Adverse Event 4. Iron Deficiency
outcomes:
Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates
1. Gastrointestinal Surgery 2. Necrotizing Enterocolitis 3. Death 4. Neonatal Death
outcomes:
Antibiotics for preventing suppurative complications from undifferentiated acute respiratory infections in children under five years of age
1. Pneumonia 2. Abscess 3. Death 4. Meningitis 5. Otitis Media 6. Hospitalization 7. Mastoiditis 8. Peritonsillar Abscess
outcomes:
Antithrombin III for critically ill patients
1. Death 2. Length Of Stay 3. Intensive Care 4. Respiratory Failure 5. Haemorrhage 6. Mechanical ventilation
outcomes:
Frequency of dressing changes for central venous access devices on catheter‐related infections
1. Pain 2. Death 3. Central Venous Catheter Related Bloodstream Infection
outcomes:
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
1. Adverse Event
outcomes:
Antifungal agents for preventing fungal infections in non‐neutropenic critically ill patients
1. Candida Colonization 2. Skin And Subcutaneous Tissue Fungal Infections 3. All Cause Mortality 4. Withdrawal Due To Adverse Events 5. Fungal Infection
outcomes:
Semi‐recumbent position versus supine position for the prevention of ventilator‐associated pneumonia in adults requiring mechanical ventilation
1. Ventilator Associated Pneumonia 2. Pressure ulcer 3. Death 4. Length Of Stay 5. Duration Of Hospital Stay 6. Intensive Care
outcomes:
Linezolid versus vancomycin for skin and soft tissue infections
1. Infection 2. Surgical Site Infection 3. Death
outcomes:
Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis
1. Sensorineural Hearing Loss 2. Epilepsy 3. Blindness 4. Developmental Delay 5. Death 6. Cerebral Palsy 7. Behavioural Disorder 8. Neurodevelopmental Delay
outcomes:
Duration of treatment for asymptomatic bacteriuria during pregnancy
1. Premature Delivery 2. Pyelonephritis 3. Low Birth Weight Infant 4. Adverse Event 5. Asymptomatic Bacteriuria
outcomes:
Steroids for symptom control in infectious mononucleosis
1. Duration of Symptom 2. Infectious Mononucleosis 3. Clinical Improvement
outcomes:
Prophylactic oral/topical non‐absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants
1. Disability 2. Visual Disability 3. Cognitive Developmental Delay 4. Developmental Delay 5. Educational Issues 6. Death 7. Cerebral Palsy 8. Fungal Infection 9. Neurodevelopmental Delay 10. Hearing Disability
outcomes:
Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants
1. Cognitive Developmental Delay 2. Hearing impairment 3. Visual Impairment 4. Developmental Delay 5. Death 6. Cerebral Palsy 7. Fungal Infection 8. Neurodevelopmental Delay
outcomes:
Prenatal education for congenital toxoplasmosis
1. Patient knowledge 2. Behavior 3. Congenital Toxoplasmosis 4. Toxoplasma Serology
outcomes:
Antibiotics for preventing lower respiratory tract infections in high‐risk children aged 12 years and under
1. Forced Expiratory Volume 1 2. Cystic Fibrosis 3. Cystic Fibrosis Pulmonary Exacerbation 4. Pseudomonal Infections 5. Death 6. Bacterial Lower Respiratory Infection 7. Pulmonary Tuberculosis 8. Adverse Event 9. HIV infection 10. Pneumocystis Pneumonia 11. Cancer
outcomes:
Heliox inhalation therapy for bronchiolitis in infants
1. Helium / Oxygen Gas For Inhalation 2. Emergency Department Patient Visit 3. Continuous Positive Airway Pressure Ventilation 4. Death 5. Duration Of Hospital Stay 6. Respiratory finding 7. Intensive Care 8. Adverse Event 9. Mechanical ventilation 10. Endotracheal intubation
outcomes:
Corticosteroids for acute bacterial meningitis
1. Neurological Morbidity 2. Hearing impairment 3. Death 4. Relapsing Fever
outcomes:
Post‐exposure passive immunisation for preventing rubella and congenital rubella syndrome
1. Rubella Viral Infections 2. Congenital Rubella Syndrome 3. Adverse Event 4. Congenital Rubella Pneumonitis
outcomes:
Beta2‐agonists for acute cough or a clinical diagnosis of acute bronchitis
1. Tremor 2. Nervousness 3. Adverse Event 4. Cough
outcomes:
Incentives and enablers to improve adherence in tuberculosis
1. Treatment Success 2. Prophylaxis 3. Clinical Cure
outcomes:
Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults
1. Gram-negative Bacterial Cellulitis 2. Death 3. Recurrent Pneumonia 4. Therapeutic Response 5. Methicillin Resistant Staphylococcus Aureus Infection
outcomes:
Surfactant therapy for bronchiolitis in critically ill infants
1. Death 2. Duration Of Hospital Stay 3. Intensive Care 4. Mechanical ventilation 5. Fraction Of Inspired Oxygen 6. Adverse Event 7. Partial Arterial Pressure Of Oxygen 8. Measurement Of Arterial Partial Pressure Of Carbon Dioxide
outcomes:
Silver‐coated endotracheal tubes for prevention of ventilator‐associated pneumonia in critically ill patients
1. Ventilator Associated Pneumonia 2. Death 3. Adverse Event
outcomes:
Interventions for prevention of herpes simplex labialis (cold sores on the lips)
1. Disease Recurrence 2. Adverse Event
outcomes:
Interventions for preventing recurrent urinary tract infection during pregnancy
1. Small For Gestational Age 2. Premature Delivery 3. Birth Weight 4. Apgar Score 5. Pyelonephritis 6. Urinary Tract Infection 7. Miscarriage
outcomes:
Vaccines for women for preventing neonatal tetanus
1. Premature Delivery 2. Fetal Death 3. Stillbirth 4. Neurological Finding 5. Neonatal Death 6. Tetanus 7. Maternal Death 8. Miscarriage 9. Adverse Event 10. Congenital Malformation
outcomes:
Antibiotic prophylaxis during the second and third trimester to reduce adverse pregnancy outcomes and morbidity
1. Puerperal Sepsis 2. Lower Urinary Tract Infection 3. Premature Delivery 4. Clinical Sepsis 5. Blood Culture 6. Puerperal Endometritis 7. Preterm Premature Rupture Of Membranes 8. Low Birth Weight Infant 9. Wound Infection
outcomes:
Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes
1. Sepsis 2. Neonatal Death 3. Maternal Death 4. Respiratory Tract Infection
outcomes:
Antibiotic lock for the prevention of catheter‐related infection in neonates
1. Catheter Related Infection 2. Death 3. Hypoglycemia
outcomes:
Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures
1. Infection 2. All Cause Mortality 3. Surgery 4. Meningitis 5. Death
outcomes:
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
1. Death
outcomes:
Leukotriene inhibitors for bronchiolitis in infants and young children
1. All Cause Mortality 2. Duration Of Hospital Stay 3. Clinical Finding 4. Adverse Event
outcomes:
Azithromycin for acute lower respiratory tract infections
1. Treatment Failure
outcomes:
Chlorhexidine skin or cord care for prevention of mortality and infections in neonates
1. Infection 2. Omphalitis 3. Death
outcomes:
Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease
1. Parenteral nutrition
outcomes:
Corticosteroids for parasitic eosinophilic meningitis
1. Clinical Resolution
outcomes:
Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomes
1. Sepsis 2. Perinatal Death 3. Neonatal Death 4. Maternal Death
outcomes:
Skin preparation with alcohol versus alcohol followed by any antiseptic for preventing bacteraemia or contamination of blood for transfusion
1. Bacteraemia 2. Sample Contaminated
outcomes:
Low dose versus high dose stavudine for treating people with HIV infection
1. Adverse Event
outcomes:
Macrolides for diffuse panbronchiolitis
1. Forced Expiratory Volume 1 2. Forced Vital Capacity 3. Lung function test 4. Survival 5. Clinical Improvement
outcomes:
Pneumococcal vaccination during pregnancy for preventing infant infection
1. Pneumonia 2. Meningitis 3. Bacteraemia 4. Sepsis 5. Neonatal Death 6. Otitis Media
outcomes:
Adjunctive hyperbaric oxygen for necrotizing fasciitis
1. Death
outcomes:
Antibiotics for community‐acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children
1. Treatment Failure
outcomes:
Antibiotic regimens for management of intra‐amniotic infection
1. Neonatal Death 2. Maternal Death
outcomes:
Surfactant for meconium aspiration syndrome in term and late preterm infants
1. Death
outcomes:
Vaginal chlorhexidine during labour to prevent early‐onset neonatal group B streptococcal infection
1. Invasive Group B Beta-hemolytic Streptococcal Disease 2. Group B Streptococcal Pneumonia
outcomes:
Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery
1. Pneumonia 2. Urinary Tract Infection 3. Intensive Care 4. Endomyometritis 5. Sepsis Of The Newborn 6. Wound Infection
outcomes:
Amantadine and rimantadine for influenza A in children and the elderly
1. Dizziness 2. Insomnia 3. Nausea And Vomiting 4. Stimulation 5. Adverse Event 6. Therapeutic Response 7. Cough 8. Fever 9. Influenza Due To Influenza A Virus
outcomes:
Antibiotics for meconium‐stained amniotic fluid in labour for preventing maternal and neonatal infections
1. Admission to Intensive Care Unit 2. Neonatal morbidity 3. Sepsis 4. Neonatal Death 5. Endometritis 6. Adverse Event 7. Mechanical ventilation 8. Drug Resistance
outcomes:
Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator‐associated pneumonia
1. Death
outcomes:
Strategies of testing for syphilis during pregnancy
1. Congenital Syphilis 2. Perinatal Death
outcomes:
Antibiotics for community‐acquired pneumonia in adult outpatients
1. Clinical Improvement
outcomes:
Antibiotics for bronchiolitis in children under two years of age
1. Wheezing 2. Crepitations 3. Oxygen Saturation 4. Time-to-Event 5. Oxygen Supplementation 6. Fever
outcomes:
Prophylaxis for Pneumocystis pneumonia (PCP) in non‐HIV immunocompromised patients
1. Pneumocystis Infections
outcomes:
Acellular vaccines for preventing whooping cough in children
1. Pertussis 2. Paroxysmal Cough 3. Efficacy
outcomes:
Topical antifungal treatments for tinea cruris and tinea corporis
1. Relapse 2. Mycological Cure 3. Clinical Cure 4. Adverse Event
outcomes:
Structural and community‐level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections
1. Sexually Transmitted Infection 2. HIV infection
outcomes:
Antibiotics for acute pyelonephritis in children
1. Recurrent Urinary Tract Infection 2. Costs and Cost Analysis 3. Bacteriuria 4. Duration Of Hospital Stay 5. Adverse Event 6. Renal parenchymal disease 7. Fever
outcomes:
Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection
1. CD4+ cell count 2. Rna 3. HIV infection 4. Viral load 5. Survival
outcomes:
Corticosteroids for dengue infection
1. Thrombocytopenia 2. Shock 3. Pulmonary Hemorrhage 4. Blood Transfusion 5. Hemorrhagic Ascites 6. Dengue fever 7. Admission to Intensive Care Unit 8. Death 9. Hospitalization 10. Seizure 11. Haemorrhage
outcomes:
Vaccines for post‐exposure prophylaxis against varicella (chickenpox) in children and adults
1. Vaccination Adverse Reaction 2. Varicella
outcomes:
Bronchodilators for bronchiolitis
1. Oxygen Saturation
outcomes:
Intrapartum antibiotics for known maternal Group B streptococcal colonization
1. Sepsis 2. Neonatal Death 3. Neonatal Pneumonia
outcomes:
Hormonal contraception for women exposed to HIV infection
1. HIV Status
outcomes:
Post‐exposure passive immunisation for preventing measles
1. Measles 2. Death 3. Adverse Event 4. Measles With Complication
outcomes:
Systemic corticosteroids for acute sinusitis
1. Time to clinical improvement 2. Clinical Resolution
outcomes:
Over‐the‐counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults
1. Treatment Failure 2. Complication 3. Adverse Event 4. Cough
outcomes:
Intermittent versus daily therapy for treating tuberculosis in children
1. All Cause Mortality 2. Relapse 3. Sputum Test 4. Weight Gain 5. Patient compliance 6. Adverse Event 7. Chest Finding
outcomes:
Beta lactam antibiotic monotherapy versus beta lactam‐aminoglycoside antibiotic combination therapy for sepsis
1. All Cause Mortality 2. Treatment Failure
outcomes:
Intranasal steroids for acute sinusitis
1. Clinical Improvement
outcomes:
Infection control strategies for preventing the transmission of meticillin‐resistant Staphylococcus aureus (MRSA) in nursing homes for older people
1. All Cause Mortality 2. Methicillin Resistant Staphylococcus Aureus Infection
outcomes:
Antibiotic therapy for the treatment of methicillin‐resistant Staphylococcus aureus (MRSA) in non surgical wounds
1. All Cause Mortality 2. Serious Adverse Event 3. Quality of Life
outcomes:
Continuous negative extrathoracic pressure or continuous positive airway pressure compared to conventional ventilation for acute hypoxaemic respiratory failure in children
1. Oxygenation Index 2. Intermittent Positive Pressure Ventilation 3. Treatment Failure 4. Continuous Positive Airway Pressure Ventilation 5. Death 6. Fraction Of Inspired Oxygen 7. Clinical Improvement
outcomes:
Combined and alternating paracetamol and ibuprofen therapy for febrile children
1. Discomfort 2. Absences 3. Dosage 4. Fever
outcomes:
Antibiotics for preventing meningococcal infections
1. Meningococcal infection 2. Death
outcomes:
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
1. All Cause Mortality 2. Death
outcomes:
Optimal timing for intravascular administration set replacement
1. Device Colonization 2. Death 3. Infection Of Bloodstream 4. Central Venous Catheter Related Bloodstream Infection
outcomes:
Antibiotics for preventing complications in children with measles
1. Pneumonia
outcomes:
Glucocorticoids for acute viral bronchiolitis in infants and young children
1. Hospital admission 2. Length Of Stay
outcomes:
Antibiotics for community‐acquired pneumonia in children
1. Treatment Failure 2. Clinical Cure
outcomes:
Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children
1. All Cause Mortality 2. Serious Adverse Event 3. Admission to Intensive Care Unit 4. Length Of Stay 5. Hospitalization 6. Mechanical ventilation 7. Oxygen Supplementation 8. Respiratory Syncytial Virus Infection
outcomes:
De‐escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock
1. Death
outcomes:
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
1. Serious Adverse Event
outcomes:
Vaccines for preventing influenza in people with asthma
1. Pneumonia 2. Death 3. Hospitalization 4. Lung function test 5. Asthma exacerbation
outcomes:
Extracorporeal membrane oxygenation for critically ill adults
1. All Cause Mortality
outcomes:
Mental Health First Aid as a tool for improving mental health and well‐being
1. Mental Health Assessment Status 2. Mental Health Treatment 3. General well-being 4. Adverse Event
outcomes:
Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones
1. Retreatment 2. Additional procedure 3. Treatment Success 4. Efficiency quotient
outcomes:
Magnetic seizure therapy for people with schizophrenia
1. Cognitive function 2. Relapse 3. Brief Psychiatric Rating Scale - 1962 4. Clinical Global Impression 5. Adverse Event 6. Positive And Negative Syndrome Scale
outcomes:
Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis
1. Forced Expiratory Volume 1 2. Cystic Fibrosis Pulmonary Exacerbation 3. Quality of Life 4. Cystic Fibrosis Quality of Life 5. Cystic Fibrosis Questionnaire-Revised 6. Patient compliance 7. Patient Satisfaction
outcomes:
Carnitine supplements for people with chronic kidney disease requiring dialysis
1. Quality of Life 2. Fatigue 3. Adverse Event
outcomes:
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
1. Quality of Life 2. Readmission 3. Adverse Event
outcomes:
Hypoxia‐inducible factor stabilisers for the anaemia of chronic kidney disease
1. Activities of Daily Living 2. Myocardial Infarction 3. Stroke 4. Blood Transfusion 5. Red Blood Cell Count 6. Fatigue 7. Cardiovascular Mortality
outcomes:
Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
1. Catatonia 2. Adverse Event
outcomes:
Cognitive behavioural therapy (group) for schizophrenia
1. Clinical Improvement
outcomes:
Negative pressure wound therapy for managing the open abdomen in non‐trauma patients
1. Primary fascial closure 2. Adverse Event
outcomes:
Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
1. Serious Adverse Event 2. Quality of Life 3. Lower urinary tract symptoms
outcomes:
Self‐management interventions for people with chronic obstructive pulmonary disease
1. Emergency Department Patient Visit 2. St George Hospital Respiratory Questionnaire 3. Hospital admission 4. Hospitalization 5. COPD Exacerbation 6. Health-Related Quality of Life 7. All Cause Mortality 8. Dyspnea 9. Hospital Anxiety And Depression Scale 10. Quality of Life 11. Depressive symptoms 12. Respiratory exacerbation 13. Death 14. Anxiety 15. Respiratory Event 16. mMRC Dyspnea Scale
outcomes:
Integrated disease management interventions for patients with chronic obstructive pulmonary disease
1. Exercise Test Finding 2. Quality of Life 3. COPD Exacerbation
outcomes:
Preoperative hair removal to reduce surgical site infection
1. Surgical Site Infection
outcomes:
Exercise training for adult lung transplant recipients
1. All Cause Mortality 2. Pathological Fracture 3. Pulmonary function 4. Aerobic capacity 5. Muscle Strength 6. Adverse Event 7. Health-Related Quality of Life
outcomes:
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD)
1. St George Hospital Respiratory Questionnaire 2. Quality of Life 3. Death 4. Hospitalization 5. COPD Exacerbation
outcomes:
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3‐5D
1. Bone Density 2. Fracture 3. Adverse Event
outcomes:
Vitamin D supplementation for the treatment of COVID‐19: a living systematic review
1. All Cause Mortality 2. Serious Adverse Event 3. Quality of Life 4. Clinical status 5. Adverse Event
outcomes:
Digital interventions for the management of chronic obstructive pulmonary disease
1. Self Efficacy 2. Dyspnea 3. 6-minute Walk Test 4. St George Hospital Respiratory Questionnaire 5. Chronic Respiratory Disease Questionnaire Dyspnea Subscale 6. Chronic Respiratory Disease Questionnaire 7. Quality of Life 8. COPD Exacerbation 9. Health Behavior
outcomes:
Exercise training for bronchiectasis
1. St George Hospital Respiratory Questionnaire 2. 6-minute Walk Test 3. Leicester Cough Questionnaire 4. Cardiopulmonary Exercise Test 5. Endurance Shuttle Walk Test 6. Walking Distance Test 7. Incremental Shuttle Walk Test
outcomes:
High versus low positive end‐expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome
1. PaO2 FiO2 measurment 2. Weaning From Mechanically Assisted Ventilation Commenced 3. Death 4. Accident Due To Extremes Of Atmospheric Pressure And To Sudden Changes In Atmospheric Pressure
outcomes:
Prevention of depression in adults with long‐term physical conditions
1. Withdrawn From Research Study 2. Depression 3. Adverse Event
outcomes:
Video games for people with schizophrenia
1. Cognitive function 2. Quality of Life 3. Social functioning 4. Functional ability 5. Adverse Event
outcomes:
Rehabilitation following surgery for flexor tendon injuries of the hand
1. Finger Joint - Range Of Movement 2. Functional Assessment 3. Functional ability 4. Adverse Event
outcomes:
Urgent‐start peritoneal dialysis versus conventional‐start peritoneal dialysis for people with chronic kidney disease
1. Peritoneal Dialysis Leakage 2. Peritoneal Catheter 3. Adjustment 4. Peritoneal dialysis complication 5. Peritoneal Dialysis Catheter Tunnel Infection 6. Malposition Of Peritoneal Dialysis Catheter 7. Haemorrhage 8. Infection Of Catheter Exit Site 9. Survival 10. Peritonitis 11. Catheter Blockage
outcomes:
Maintenance treatment with antipsychotic drugs for schizophrenia
1. Withdrawn From Research Study 2. Relapse 3. Employment 4. Quality of Life 5. Hospitalization 6. Suicide 7. Social functioning
outcomes:
Psychosocial interventions for conversion and dissociative disorders in adults
1. Global Assessment Of Functioning 2. Conversion disorder 3. Quality of Life Inventory 4. Quality of Life 5. Work and Social Adjustment Scale 6. Adverse Event 7. Functional ability
outcomes:
Repositioning for pressure injury prevention in adults
1. Pressure ulcer
outcomes:
Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women
1. Faecal incontinence 2. International Consultation On Incontinence Questionnaire Short Form 3. Quality of Life 4. Urinary Incontinence 5. Patient-Reported Outcome
outcomes:
Non‐steroidal anti‐inflammatory drugs for acute low back pain
1. Disability 2. Pain 3. Global Assessment 4. Adverse Event 5. Functional ability 6. Return to Work 7. Clinical Improvement 8. Pain Intensity
outcomes:
Subcuticular sutures for skin closure in non‐obstetric surgery
1. Surgical Site Infection 2. Cosmesis 3. Wound Complication 4. Costs and Cost Analysis 5. Wound Closure 6. Wound Dehiscence 7. Patient Satisfaction
outcomes:
Epidural corticosteroid injections for lumbosacral radicular pain
1. Disability 2. Leg Pain 3. Serious Adverse Event 4. Adverse Event 5. Pain Intensity
outcomes:
Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit
1. Delirium 2. Death 3. Duration Of Hospital Stay 4. Readmission 5. Adverse Event 6. Discharge 7. Physical Restraint
outcomes:
Percutaneous pinning for treating distal radial fractures in adults
1. Infection 2. Grip Strength 3. Complex Regional Pain Syndrome 4. Surgery 5. Assessment Using Patient Rated Wrist Evaluation Scale 6. Joint Stiffness 7. Assessment Using Disabilities Of The Arm Shoulder And Hand Outcome Measure 8. Assessment Using Quick Disabilities Of The Arm Shoulder And Hand Outcome Measure 9. Complication 10. Assessment Using Michigan Hand Outcomes Questionnaire 11. Patient-Reported Outcome
outcomes:
Pharmacological interventions for treatment‐resistant depression in adults
1. Treatment Withdrawal 2. Depressive Disorder In Remission 3. Quality of Life 4. Depressive symptoms 5. Therapeutic Response
outcomes:
Transcutaneous electrical nerve stimulation (TENS) for chronic neck pain
1. Disability 2. Visual Analog Pain Scale 3. Pain 4. Adverse Event
outcomes:
Modafinil for people with schizophrenia or related disorders
1. Cognitive function 2. Withdrawn From Research Study 3. Quality of Life 4. Mental State Finding 5. Hospitalization 6. Global Assessment 7. Adverse Event
outcomes:
Perioperative restrictive versus goal‐directed fluid therapy for adults undergoing major non‐cardiac surgery
1. Renal Failure 2. Serious Adverse Event 3. Personal cost of illness 4. Delayed Surgical Recovery 5. Complication 6. Length Of Stay 7. Inotropic agent 8. Antihypertensive agents
outcomes:
Treatments for primary delusional infestation
1. Withdrawn From Research Study 2. Quality of Life 3. Mental State Finding 4. Global Assessment 5. Adverse Event
outcomes:
Interventions for prodromal stage of psychosis
1. Psychosis 2. Withdrawn From Research Study 3. Suicidal Thoughts 4. Behavior 5. Quality of Life 6. Prodrome 7. Psychopathology 8. Global Assessment 9. Adverse Event 10. Transient psychosis
outcomes:
Surgical versus conservative interventions for treating acromioclavicular dislocation of the shoulder in adults
1. Returns To Baseline Activity Status 2. Pain 3. Treatment Failure 4. Assessment Using Disabilities Of The Arm Shoulder And Hand Outcome Measure 5. Return to Work 6. Adverse Event 7. Health-Related Quality of Life 8. Patient Satisfaction
outcomes:
Acetylsalicylic acid (aspirin) for schizophrenia
1. Cognitive function 2. Gastrointestinal findings 3. Mental State Finding 4. Clinical Global Impression
outcomes:
Rigid dressings versus soft dressings for transtibial amputations
1. Costs and Cost Analysis 2. Quality of Life 3. Complication 4. Duration Of Hospital Stay 5. Wound Healing 6. Functional ability 7. Adverse Event 8. Patient Satisfaction
outcomes:
Head‐to‐head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease
1. Forced Expiratory Volume 1 2. All Cause Mortality 3. Serious Adverse Event 4. Chronic Respiratory Disease Questionnaire 5. Quality of Life 6. Bacterial Resistance 7. COPD Exacerbation
outcomes:
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
1. Forced Expiratory Volume 1 2. St George Hospital Respiratory Questionnaire 3. Death 4. Hospitalization 5. Limitation Of Activities Due To Disability 6. COPD Exacerbation 7. Adverse Event 8. Health-Related Quality of Life
outcomes:
Conservative management following closed reduction of traumatic anterior dislocation of the shoulder
1. Shoulder instability 2. Returns To Baseline Activity Status 3. Functional Performance And Activity 4. Quality of Life 5. Adverse Event 6. Return to Work 7. Functional ability 8. Patient Satisfaction
outcomes:
Interventions for preventing high altitude illness: Part 3. Miscellaneous and non‐pharmacological interventions
1. Acute Mountain Sickness
outcomes:
Peer support for people with schizophrenia or other serious mental illness
1. All Cause Mortality 2. Relapse 3. Costs and Cost Analysis 4. Duration Of Hospital Stay 5. Hospitalism
outcomes:
Subfascial endoscopic perforator surgery (SEPS) for treating venous leg ulcers
1. Recurrent Venous Leg Ulcer 2. Pain 3. Quality of Life 4. Wound Healing 5. Adverse Event 6. Time-to-Event
outcomes:
Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
1. Serious Adverse Event 2. Repeat surgery 3. Finding Of Ejaculation 4. Quality of Life 5. Lower urinary tract symptoms 6. Erectile function
outcomes:
Immunonutrition for acute respiratory distress syndrome (ARDS) in adults
1. All Cause Mortality 2. Cardiovascular Event 3. Length Of Stay 4. Oxygenation Monitoring 5. Gastrointestinal Tract Finding 6. Intensive Care 7. Mechanical ventilation 8. Adverse Event
outcomes:
Subacromial decompression surgery for rotator cuff disease
1. Disability 2. Serious Adverse Event 3. Pain 4. Treatment Success 5. Global Assessment 6. Adverse Event 7. Functional ability 8. Health-Related Quality of Life
outcomes:
Deep brain stimulation for dystonia
1. General Clinical State Finding 2. Burke-Fahn-Marsden Dystonia Rating Scale 3. Drug Tolerance 4. Visual Analog Scale 5. Health Status Index 6. Emotional State 7. Functional Status Index 8. Clinical Global Impression 9. Adverse Event 10. Toronto Western Spasmodic Torticollis Rating Scale 11. Beck Depression Inventory
outcomes:
Effects of peri‐operative nonsteroidal anti‐inflammatory drugs on post‐operative kidney function for adults with normal kidney function
1. All Cause Mortality 2. Renal Replacement 3. Acute Renal Failure 4. Serum Creatinine 5. Duration Of Hospital Stay
outcomes:
Laryngeal mask airway versus endotracheal tube for percutaneous dilatational tracheostomy in critically ill adults
1. All Cause Mortality 2. Serious Adverse Event 3. Percutaneous Dilational Tracheostomy 4. Treatment Failure 5. Duration Of Surgery 6. Death
outcomes:
Perioperative alcohol cessation intervention for postoperative complications
1. Postoperative Complication 2. Abstains From Alcohol 3. Death
outcomes:
Chlorpromazine versus piperacetazine for schizophrenia
1. Withdrawn From Research Study 2. Costs and Cost Analysis 3. Mental State Finding 4. Global Assessment 5. Adverse Event
outcomes:
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
1. Forced Expiratory Volume 1 2. All Cause Mortality 3. Serious Adverse Event 4. St George Hospital Respiratory Questionnaire 5. Chronic Respiratory Disease Questionnaire 6. Quality of Life 7. COPD Exacerbation 8. Adverse Event
outcomes:
Antibiotics for exacerbations of chronic obstructive pulmonary disease
1. Treatment Failure 2. Diarrhea 3. Death 4. Adverse Event
outcomes:
Occupational therapy delivered by specialists versus non‐specialists for people with schizophrenia
1. Global Assessment 2. Adverse Event 3. Activities Of Daily Living Assessment
outcomes:
Phosphate binders for preventing and treating chronic kidney disease‐mineral and bone disorder (CKD‐MBD)
1. Calcification Of Coronary Artery 2. Hypercalcemia 3. All Cause Mortality 4. Serum Phosphate 5. Vomiting 6. Cardiovascular Mortality 7. Nausea 8. Constipation
outcomes:
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients
1. Length of ICU Stay 2. Drugs for Antiinfectives For Systemic Use 3. Quality of Life 4. Death 5. Sepsis 6. Time-to-Event
outcomes:
Fluphenazine (oral) versus placebo for schizophrenia
1. Anticholinergics 2. Relapse 3. Extrapyramidal Sign 4. Global Assessment 5. Adverse Event
outcomes:
Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults
1. Pain 2. Postoperative Ileus 3. Bowel Sounds 4. Adverse Event 5. Time-to-Event 6. Defecation Reflex Finding 7. Passing Flatus
outcomes:
Psychological therapies for treatment‐resistant depression in adults
1. Treatment Withdrawal 2. Depressive Disorder In Remission 3. Depressive symptoms 4. Depression 5. Clinician-Reported Outcome 6. Therapeutic Response 7. Patient-Reported Outcome
outcomes:
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia
1. Quality of Life 2. Duration Of Hospital Stay 3. Mental State Finding 4. Brief Psychiatric Rating Scale - 1962 5. Global Assessment 6. Adverse Event
outcomes:
Laparoscopic‐endoscopic rendezvous versus preoperative endoscopic sphincterotomy in people undergoing laparoscopic cholecystectomy for stones in the gallbladder and bile duct
1. All Cause Mortality 2. Bile duct clearance 3. Postoperative Acute Pancreatitis 4. Morbidity
outcomes:
Risperidone for psychosis‐induced aggression or agitation (rapid tranquillisation)
1. Movement Disorder 2. Costs and Cost Analysis 3. Akathisia 4. Adverse Event 5. Awake 6. Barthel Index 7. Positive And Negative Syndrome Scale
outcomes:
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
1. Forced Expiratory Volume 1 2. Relapse 3. Adverse Drug Reaction 4. Treatment Failure 5. Hyperglycinemia 6. Quality of Life 7. Death 8. Duration Of Hospital Stay 9. Hospitalization
outcomes:
Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
1. Withdrawn From Research Study 2. Social Network 3. Extrapyramidal Sign 4. Tardive dyskinesia 5. Social inclusion
outcomes:
Fitness training for cardiorespiratory conditioning after traumatic brain injury
1. Physical fitness 2. Depression 3. Fatigue 4. Normal Cognition 5. Adverse Event
outcomes:
Peritoneal dialysis for acute kidney injury
1. All Cause Mortality 2. Fluids 3. Renal Function Monitoring 4. Adequacy Of Dialysis 5. Infection As Complication Of Medical Care 6. Acidosis 7. Time-to-Event 8. Renal Dialysis
outcomes:
Personalised asthma action plans for adults with asthma
1. Emergency Care 2. Adverse Event 3. Asthma exacerbation
outcomes:
Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease
1. Forced Expiratory Volume 1 2. Quality of Life 3. Death